Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors

被引：0
|
作者：
Moreno, Amy [1 ]
Akcakanat, Argun [1 ]
Munsell, Mark F. [1 ]
Soni, Alpana [1 ]
Yao, James [1 ]
Meric-Bernstam, Funda [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3583S / 3583S
页数：1
相关论文
共 50 条
  • [21] LONG ACTING OCTREOTIDE IN PTS WITH DISSEMINATED NEUROENDOCRINE TUMORS
    Markovich, A.
    Emelianova, G.
    Gorbounova, V.
    Bruzgin, V.
    Orel, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 382 - 382
  • [22] Treatment of gastroenteropancreatic neuroendocrine tumors with octreotide LAR.
    Tomassetti, P
    Migliori, M
    Lalli, S
    Corinaldesi, R
    Gullo, L
    GASTROENTEROLOGY, 2000, 118 (04) : A526 - A526
  • [23] Study of the course of neuroendocrine tumors with 111In-octreotide
    Ramos, J
    Maraña, G
    Tabuenca, MJ
    Castejón, I
    Ayllón, LJ
    Berrocal, JO
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S356 - S356
  • [24] Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors
    Woltering, EA
    Mamikunian, PM
    Zietz, S
    Krutzik, SR
    Go, VLW
    Vinik, AI
    Vinik, E
    O'Dorisio, TM
    Mamikunian, G
    PANCREAS, 2005, 31 (04) : 392 - 400
  • [25] Combination of non-cytotoxic agents with anti-angiogenic activity for metronomic therapy of solid tumors: Antitumor activity and biological effects
    Noberasco, Cristina
    Spitaleri, Gianluca
    Mancuso, Patrizia
    Milani, Alessandra
    Rocca, Andrea
    Bertolini, Francesco
    Curigliano, Giuseppe
    de Pas, Tommaso
    Boselli, Sabrina
    de Braud, Filippo
    ANNALS OF ONCOLOGY, 2007, 18 : 87 - 87
  • [26] Design and preclinical evaluation of single agents with antitubulin and antiangiogenic activity as antitumor agents
    Gangjee, Aleem
    Pavana, Roheeth Kumar
    Zhang, Xin
    Ihnat, Michael
    Hamel, Ernest
    CANCER RESEARCH, 2012, 72
  • [27] OCTREOTIDE AS AN ANTINEOPLASTIC AGENT IN THE TREATMENT OF FUNCTIONAL AND NONFUNCTIONAL NEUROENDOCRINE TUMORS
    SALTZ, L
    TROCHANOWSKI, B
    BUCKLEY, M
    HEFFERNAN, B
    NIEDZWIECKI, D
    TAO, Y
    KELSEN, D
    CANCER, 1993, 72 (01) : 244 - 248
  • [28] Antitumor Effect of Somatostatin Analogs in Neuroendocrine Tumors
    Chua, Yu Jo
    Michael, Michael
    Zalcberg, John R.
    Hicks, Rod J.
    Goldstein, David
    Liauw, Winston
    Price, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : E41 - E42
  • [29] Antitumor Effects of Somatostatin Analogs in Neuroendocrine Tumors
    Sideris, Lucas
    Dube, Pierre
    Rinke, Anja
    ONCOLOGIST, 2012, 17 (06): : 747 - 755
  • [30] Role of octreotide scan for evaluation of primary and metastatic neuroendocrine tumors
    Rathore, Bhawana
    Holdeman, Karen
    Zahiri, Homeira
    Paknikar, Subhash
    Hankins, Jordan
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
12345